Ipilimumab (Yervoy) for Metastatic Melanoma

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2011年 / 53卷 / 1367期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [31] Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    Lawrence, Donald
    Lezcano, Cecilia
    Wu, Xinqi
    Zhou, Jun
    Sasada, Tetsuro
    Zeng, Wanyong
    Giobbie-Hurder, Anita
    Atkins, Michael B.
    Ibrahim, Nageatte
    Friedlander, Philip
    Flaherty, Keith T.
    Murphy, George F.
    Rodig, Scott
    Velazquez, Elsa F.
    Mihm, Martin C., Jr.
    Russell, Sara
    DiPiro, Pamela J.
    Yap, Jeffrey T.
    Ramaiya, Nikhil
    van den Abbeele, Annick D.
    Gargano, Maria
    McDermott, David
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 632 - 642
  • [32] Ipilimumab plus temozolomide in metastatic melanoma.
    Patel, S. P.
    Bedikian, A. Y.
    Papadopoulos, N. E.
    Hwu, W.
    Kim, K. B.
    Homsi, J.
    Davies, M. A.
    Woodman, S. E.
    Radvanyi, L. G.
    Woodard, K.
    Mahoney, S.
    Hwu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] PREDICTORS OF SURVIVAL FOR THERAPY WITH IPILIMUMAB IN METASTATIC MELANOMA
    Valpione, S.
    Bazzi, M.
    Piccin, L.
    Pigozzo, J.
    Chiarion-Sileni, V.
    ANNALS OF ONCOLOGY, 2014, 25
  • [34] Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)
    Bakacs, Tibor
    Mehrishi, Jitendra N.
    Szabo, Miklos
    Moss, Ralph W.
    PHARMACOLOGICAL RESEARCH, 2012, 66 (02) : 192 - 197
  • [35] Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma
    Li, Mengqian
    LANCET ONCOLOGY, 2021, 22 (08): : E342 - E342
  • [36] An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma
    Hasanov, Merve
    Milton, Denai R.
    Sharfman, William H.
    Taback, Bret
    Cranmer, Lee D.
    Daniels, Gregory A.
    Flaherty, Lawrence
    Hallmeyer, Sigrun
    Milhem, Mohammed
    Feun, Lynn
    Hauke, Ralph
    Doolittle, Gary
    Gregory, Nancy
    Patel, Sapna
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [37] MELANOMA OPDIVO® + YERVOY® Combination: Impressive Efficacy in Melanoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (06) : 4 - 5
  • [38] Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
    Robert, Caroline
    Thomas, Luc
    Bondarenko, Igor
    O'Day, Steven
    Weber, Jeffrey
    Garbe, Claus
    Lebbe, Celeste
    Baurain, Jean-Francois
    Testori, Alessandro
    Grob, Jean-Jacques
    Davidson, Neville
    Richards, Jon
    Maio, Michele
    Hauschild, Axel
    Miller, Wilson H., Jr.
    Gascon, Pere
    Lotem, Michal
    Harmankaya, Kaan
    Ibrahim, Ramy
    Francis, Stephen
    Chen, Tai-Tsang
    Humphrey, Rachel
    Hoos, Axel
    Wolchok, Jedd D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26): : 2517 - 2526
  • [39] Enterocolitis in a Patient Being Treated With Ipilimumab for Metastatic Melanoma
    Koch, Christine
    Paetzold, Sylvie
    Trojan, Joerg
    GASTROENTEROLOGY, 2012, 143 (02) : 298 - 505
  • [40] Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma
    Formozo, A. A.
    Gomes, J. R.
    Schmerling, R. A.
    Buzaid, A. C.
    JOURNAL OF SKIN CANCER, 2021, 2021
12345